Dexedrine (Dextroamphetamine)
Use
The Dexedrine (Dextroamphetamine) test is utilized to monitor therapeutic levels and detect the presence of dextroamphetamine in plasma or serum samples. It is essential for individuals prescribed with Dexedrine for attention deficit hyperactivity disorder (ADHD) and narcolepsy, ensuring dosage is within the therapeutic range and preventing possible toxicity or abuse.
Special Instructions
Not provided.
Limitations
Plasma or serum gel tubes are not acceptable and can lead to sample rejection. Hemolysis, lipemia, icterus, and other unspecified conditions are considered as potential causes for rejection. Minimum volume requirement of 2 mL is crucial to obtain clinically relevant results and avoid rejection due to insufficient volume.
New York Approved
Methodology
Mass Spectrometry (GC-MS)
Biomarkers
Dextroamphetamine
Analyte
LOINC Codes
- 9814-5 - D-amphet SerPl-mCnc
- 9814-5 - D-amphet SerPl-mCnc
Result Turnaround Time
5-9 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
5 mL
Minimum Volume
2 mL
Container
plastic vial
Collection Instructions
Draw blood in a green-top (sodium heparin) tube(s), plasma gel tube is not acceptable. Spin down and send sodium heparin plasma refrigerated in a plastic vial.
Causes for Rejection
Hemolysis, lipemia, icterus, other unspecified conditions, use of plasma gel tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 180 days |